Consequently, crucial information—such as the serum glucose levels and glycated hemoglobin concentrations of patients with T2DM, the severity of T2DM-related complications, treatment responses after SGLT2 inhibitor use, details of other comorbidities such as human papillomavirus infection and sexual intercourse, actual sites of cervical cancer, imaging results related to cervical cancer, pathological reports of cervical cancer, responses to treatment for cervical cancer, and recurrence of cervical cancer (if any)—was not considered in our study. Here, SLC5A2 is linked to cervical cancer.